Real-time SEC alerts Start Free →
Profitelligence
Medtronic plc
MDT MEDIUM Impact

Medtronic plc

Medtronic Announces €3 Billion Notes Offering

| 8-K |Healthcare

Summary

On June 3, 2024, Medtronic plc announced a €3 billion senior notes offering, consisting of €850 million of 3.650% notes due 2029, €850 million of 3.875% notes due 2036, €600 million of 4.150% notes due 2043, and €700 million of 4.150% notes due 2053. The notes were issued under an indenture and are fully guaranteed by Medtronic Global Holdings S.C.A. and Medtronic plc. Medtronic expects to use the net proceeds for general corporate purposes, including debt repayment. The offering's financial impact was reflected in Medtronic's fiscal year 2025 adjusted earnings per share guidance.

Profitelligence Profitelligence Alerts

Get alerts for MDT

Be first to know when Medtronic plc files with the SEC.

Set Up Alerts →

Filing Categories

New Major Contract Financial Instrument Agreement Regulation FD Disclosure Corporate Update No viable tag

Exhibits (6)

Advertisement

About Medtronic plc

Medtronic plc is a leading global healthcare technology company that designs, manufactures, and sells innovative medical devices and therapies used in various medical procedures. The primary function of Medtronic is to improve healthcare outcomes by providing advanced therapeutic solutions. Its extensive product portfolio includes cardiac and vascular devices, diabetes-related products, minimally invasive therapies, and neurosurgical technologies. Medtronic plays a vital role in the medical device industry, catering to cardiovascular treatment, advanced diabetes management, spinal and musculoskeletal therapy, and more. Notably, the company is renowned for its pacemaker technology and is a pivotal player in cardiac care. The company's innovations significantly impact the healthcare sector by enhancing the quality of life for patients worldwide and improving the effectiveness of medical treatments. As a key player in the medical device market, Medtronic is instrumental in setting industry standards and advancing medical technology through continuous research and development. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic's global presence underscores its substantial contribution to the healthcare industry across various continents.

Exchange: NYSE Industry: Medical Devices Company Website →

Official SEC Documents

MDT
MDT Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement